【millermatic 200 for sale】Roche Gets Emergency FDA Approval For Covid-19 Antibody Test, Starts Shipping
时间:2024-09-29 12:22:58 出处:Exploration阅读(143)
Switzerland’s Roche Holding AG (
RHHBY
) announced on Sunday that its antibody test,millermatic 200 for sale which seeks to determine if an individual has been infected with the coronavirus, has received emergency approval by the U.S. Food and Drug Administration (FDA).
“We are now able to deliver a high-quality antibody test in high quantities, so we can support healthcare systems around the world with an important tool to better manage the COVID-19 health crisis,” said Severin Schwan, CEO of the Roche Group. ”I am in particular pleased about the high specificity and sensitivity of our test, which is crucial to support health care systems around the world with a reliable tool to better manage the COVID-19 health crisis.”
The Swiss drugmaker said it has already started shipping the antibody tests to leading laboratories around the world and will ramp up production capacity to provide “high double-digit millions” of tests in May to healthcare systems in countries accepting the European CE regulatory mark as well as the U.S.
The antibody test, which has a specificity greater than 99.8% and 100% sensitivity aims to help assess patients’ immune response to the virus, the drugmaker said.
HSBC analyst
Stephen McGarry
on Thursday raised the stock to Hold from Sell, saying that the drugmaker represents one of the more secure bets within the pharmaceutical sector.
McGarry noted that compared to other industries, sales and cash flows of the pharmaceutical industry in the Covid-19 realm are well protected.
The two Wall Street analysts covering the stock in the past three months are split between a Buy and a Hold rating adding up to a Moderate Buy consensus rating. The $48 average
price target
indicates that they see 12% upside potential in the shares in the next 12 months.
Related News:
Gilead’s Remdesivir Receives Emergency FDA Approval; Here’s What This Five-Star Analyst Has To Say
Gilead Down 5% As Q1 Earnings Spark Street Downgrades
Vaxart Shows Strong Progress in Its COVID-19 Program; 5-Star Analyst Boosts Price Target
View comments
上一篇: Terms for Nykredit's and Totalkredit's auctions - Totalkredit A/S
下一篇: Global core material market size to record unprecedented growth through 2025
猜你喜欢
- Should You Buy AMD Stock?
- What Cineworld Group plc’s (LON:CINE) ROE Can Tell Us
- Alm. Brand – Report on trading in Alm. Brand A/S shares by executives and their related parties
- GLOBAL MARKETS-Rally pauses ahead of ECB stimulus plan
- Lockheed Martin (LMT) Wins $1B Deal for Super Hercules Fleet
- Aptose to Hold Corporate Update Sunday, December 6th
- Coronavirus spread in Canada is slowing - Public Health Agency
- The Global Military Ground Robot Market is expected to grow by $ 42.08 bn during 2020-2024 progressing at a CAGR of 27% during the forecast period
- SailPoint (SAIL) to Report Q3 Earnings: What's in the Offing?